Seltzer, J. H., Farrell, A., Goldenberg, N., Hornik, C., Keene, D., Krucoff, M. W., … Gajjar, D. (2020). Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank. Am Heart J, 224, 138–147. https://doi.org/10.1016/j.ahj.2020.02.012

Seltzer, Jonathan H., Ann Farrell, Neil Goldenberg, Christoph Hornik, Daniel Keene, Mitchell W. Krucoff, Concetta Lipardi, et al. “Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank.” Am Heart J 224 (June 2020): 138–47. https://doi.org/10.1016/j.ahj.2020.02.012.

Seltzer JH, Farrell A, Goldenberg N, Hornik C, Keene D, Krucoff MW, et al. Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank. Am Heart J. 2020 Jun;224:138–47.

Seltzer, Jonathan H., et al. “Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank.” Am Heart J, vol. 224, June 2020, pp. 138–47. Pubmed, doi:10.1016/j.ahj.2020.02.012.

Seltzer JH, Farrell A, Goldenberg N, Hornik C, Keene D, Krucoff MW, Lipardi C, Massicotte P, Mentzer D, Monagle P, Thornburg C, Revkin JH, Walker S, Gajjar D. Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank. Am Heart J. 2020 Jun;224:138–147.